The risk associated with organophosphorus nerve agents: from their discovery to their unavoidable threat, current medical countermeasures and perspectives

C Voros, J Dias, CM Timperley, F Nachon… - Chemico-biological …, 2024 - Elsevier
The first organophosphorus nerve agent was discovered accidently during the development
of pesticides, shortly after the first use of chemical weapons (chlorine, phosgene) on the …

Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning

PM Lundy, MG Hamilton, TW Sawyer, J Mikler - Toxicology, 2011 - Elsevier
Abstract The oximes pralidoxime (2-PAM), its dimethanesulphonate salt derivative P2S, and
obidoxime (toxogonin) are currently licensed and fielded for the treatment of chemical …

A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides

CM Wilhelm, TH Snider, MC Babin, DA Jett… - Toxicology and applied …, 2014 - Elsevier
The currently fielded pre-hospital therapeutic regimen for the treatment of
organophosphorus (OP) poisoning in the United States (US) is the administration of atropine …

Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro

F Worek, T Seeger, M Goldsmith, Y Ashani… - Archives of …, 2014 - Springer
The potent human toxicity of organophosphorus (OP) nerve agents calls for the development
of effective antidotes. Standard treatment for nerve agent poisoning with atropine and an …

Probing the activity of a non-oxime reactivator for acetylcholinesterase inhibited by organophosphorus nerve agents

CL Cadieux, H Wang, Y Zhang, JA Koenig… - Chemico-biological …, 2016 - Elsevier
Currently fielded treatments for nerve agent intoxication include atropine, an acetylcholine
receptor antagonist, and pralidoxime (2PAM), a small molecule reactivator of …

Reactivation of brain acetylcholinesterase by monoisonitrosoacetone increases the therapeutic efficacy against nerve agents in guinea pigs

JW Skovira, JC O'Donnell, I Koplovitz, RK Kan… - Chemico-biological …, 2010 - Elsevier
Current oxime therapies do not readily cross the blood–brain barrier to reactivate
organophosphorus nerve agent-inhibited cholinesterase (ChE) within the CNS. We …

Zebrafish as a model for acetylcholinesterase‐inhibiting organophosphorus agent exposure and oxime reactivation

JA Koenig, TL Dao, RK Kan… - Annals of the New York …, 2016 - Wiley Online Library
The current research progression efforts for investigating novel treatments for exposure to
organophosphorus (OP) compounds that inhibit acetylcholinesterase (AChE), including …

[HTML][HTML] Non-quaternary oximes detoxify nerve agents and reactivate nerve agent-inhibited human butyrylcholinesterase

G Amitai, A Plotnikov, S Chapman, S Lazar… - Communications …, 2021 - nature.com
Government-sanctioned use of nerve agents (NA) has escalated dramatically in recent
years. Oxime reactivators of organophosphate (OP)-inhibited acetylcholinesterase (AChE) …

Redox status in liver of rats following subchronic exposure to the combination of low dose dichlorvos and deltamethrin

MY Xu, P Wang, YJ Sun, HP Wang, YJ Liang… - Pesticide biochemistry …, 2015 - Elsevier
Organophosphates and pyrethroids are widely used pesticides with prominent toxicity to
humans. However, their joint toxicity has not been thoroughly investigated. In this study, we …

Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach

F Worek, T Wille, N Aurbek, P Eyer… - Toxicology and applied …, 2010 - Elsevier
Treatment of poisoning by highly toxic organophosphorus compounds (OP, nerve agents) is
a continuous challenge. Standard treatment with atropine and a clinically used oxime …